January 2010 Funding the Future - The ASCO Cancer Foundation® Looks Ahead Look inside: Select One

Spotlight ASCO Rings the NYSE Bell On August 19, The ASCO Cancer Foundation® and ASCO joined the ranks of the many notable businesses, organizations, and celebrities that have rung the New York Stock Exchange's Closing Bell.® ASCO Continues Successful Leadership Development Program The Leadership Development Program provides participants with extensive exposure to the roles and mission of ASCO and the Society's powerful place in developing the future of cancer care. QOPI® Certification Program Promotes Excellence in Cancer Care ASCO has launched the Quality Oncology Practice Initiative (QOPI®) Certification Program to recognize oncology practices that achieve rigorous standards for high-quality cancer care. Current Controversies in Oncology The Controversy: CT Colonography for Colorectal Cancer Screening vs. Optical Colonoscopy Abraham H. Dachman, MD, Hemant K. Roy, MD, and Michael J. Goldberg, MD, debate the use of optical colonoscopy versus CT colonography to detect precancerous and cancerous polyps. ASCO News & Forum wants to hear from you.

Online Exclusives

Scientific Highlights from Other Meetings: Joint ECCO 15-34th ESMO Multidisciplinary Congress; ACRIN 2009 Annual Meeting: Chris Twelves, MD, PhD, and Fortunato Ciardiello, MD, PhD, recap the Joint ECCO 15-34th ESMO meeting, "A Unified Approach Marking a Meeting of "Firsts"; Mitchell D. Schnall, MD, PhD, recaps the ACRIN 2009 Annual Meeting: Ten Years of Advancing Imaging Research

Spotlight on State Affiliates: Northern New England Clinical Oncology Society: President Steven M. Grunberg, MD, and Executive Director Lori Aubrey speak on behalf of NNECOS about the society’s accomplishments and future challenges.

Clinical Practice Guidelines - ASCO Guideline Update on Chemotherapy for Stage IV NSCLC: The present edition of ASCO's Guideline Update includes a new section on biomarkers, a focus on age and performance status, and recommendations regarding several new agents approved by the FDA since 2003.

NCI Program Highlights - Putting Minds and Words Together: The NCI, C-Change Cooperative Effort in Communication: C-Change, including NCI, ASCO, and other national cancer leaders, has worked to unite the entire cancer community around a core set of consumer-tested messages related to reducing people’s risk for cancer.

Family of Websites - ASCO University™ Provides Interactive, Social Learning for Oncology Professionals: Jamie Von Roenn, MD, discusses how ASCO University™ provides users with a diverse collection of content and supporting resources.